Peter Hillmen Selected Research

Abdominal Pain (Pain, Abdominal)

9/2022	Effect of eculizumab treatment in patients with paroxysmal nocturnal hemoglobinuria with or without high disease activity: Real-world findings from the International Paroxysmal Nocturnal Hemoglobinuria Registry.
7/2013	Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria.
5/2007	Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Hillmen Research Topics

Disease

82	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2024 - 01/2002
26	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 09/2022 - 05/2002
25	Hemolysis 09/2022 - 01/2002
21	Neoplasms (Cancer) 12/2023 - 01/2002
16	Disease Progression 12/2023 - 03/2004
16	Residual Neoplasm 12/2022 - 03/2004
15	Infections 12/2023 - 01/2002
14	Fatigue 09/2022 - 09/2006
9	Diarrhea 01/2021 - 07/2014
8	Thrombosis (Thrombus) 01/2020 - 11/2003
8	Neutropenia 01/2019 - 05/2015
7	Hemorrhage 10/2023 - 11/2003
7	Atrial Fibrillation 10/2023 - 03/2015
6	Hypertension (High Blood Pressure) 01/2023 - 05/2010
5	Anemia 09/2022 - 04/2005
5	Chronic Disease (Chronic Diseases) 09/2022 - 09/2006
5	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2018 - 04/2005
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 08/2003
4	Lymphocytosis 01/2020 - 08/2008
4	Cough 01/2019 - 07/2014
4	Nausea 12/2018 - 12/2007
4	Pulmonary Hypertension 07/2013 - 04/2005
3	Hemoglobinuria 09/2022 - 02/2004
3	Abdominal Pain (Pain, Abdominal) 09/2022 - 05/2007
3	Leukemia 12/2020 - 02/2006
3	Fever (Fevers) 12/2018 - 07/2014
3	Cytopenia 12/2013 - 01/2002
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 01/2023
2	Injection Site Reaction 09/2022 - 01/2021
2	Erectile Dysfunction 09/2022 - 05/2007
2	Deglutition Disorders (Dysphagia) 09/2022 - 05/2007
2	Headache (Headaches) 01/2021 - 01/2019
2	Aplastic Anemia (Anemia, Hypoplastic) 11/2019 - 01/2018
2	B-Cell Lymphoma (Lymphoma, B Cell) 05/2019 - 01/2018
2	Pneumonia (Pneumonitis) 01/2019 - 01/2017
2	Hematologic Neoplasms (Hematological Malignancy) 12/2018 - 03/2002
2	Tumor Lysis Syndrome 12/2018 - 03/2018
2	Febrile Neutropenia 03/2018 - 01/2017
2	Thrombocytopenia (Thrombopenia) 01/2017 - 02/2008
2	Lymphadenopathy 01/2017 - 04/2010
2	Vomiting 12/2015 - 12/2007
2	Lymphoid Leukemia 07/2014 - 01/2004
2	Chronic Renal Insufficiency 07/2013 - 08/2010
1	Opportunistic Infections (Opportunistic Infection) 01/2024
1	Leukopenia 01/2023
1	Heart Diseases (Heart Disease) 01/2023
1	Dyspnea (Shortness of Breath) 09/2022
1	Nasopharyngitis 09/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2021
1	Atrial Flutter (Flutter, Atrial) 11/2021

Drug/Important Bio-Agent (IBA)

41	ibrutinibIBA 12/2023 - 07/2014
27	eculizumab FDA Link 09/2022 - 02/2004
19	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023 - 01/2016
17	Rituximab (Mabthera)FDA Link 01/2023 - 02/2004
13	fludarabineIBA 01/2023 - 03/2002
13	Complement System Proteins (Complement)IBA 01/2021 - 01/2002
13	Alemtuzumab (Campath)FDA Link 01/2017 - 01/2002
10	ofatumumab FDA Link 01/2020 - 04/2010
9	venetoclaxIBA 04/2024 - 01/2018
9	Chlorambucil (Leukeran)FDA Link 01/2022 - 12/2007
9	acalabrutinibIBA 01/2022 - 01/2016
8	idelalisibIBA 01/2021 - 03/2014
6	zanubrutinibIBA 12/2023 - 04/2020
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 04/2005
5	Monoclonal AntibodiesIBA 12/2022 - 03/2002
5	Bendamustine Hydrochloride FDA Link 01/2022 - 01/2017
5	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 08/2021 - 05/2002
5	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2013 - 10/2005
4	Proteins (Proteins, Gene)FDA Link 03/2018 - 01/2002
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2012 - 04/2005
4	Complement Inactivating AgentsIBA 08/2010 - 09/2006
3	serum P-component (CIt)IBA 10/2021 - 11/2018
3	GPI-Linked ProteinsIBA 08/2021 - 01/2004
3	Hemoglobins (Hemoglobin)IBA 01/2021 - 04/2005
3	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 11/2019 - 12/2007
2	obinutuzumabIBA 12/2022 - 01/2019
2	pegcetacoplanIBA 09/2022 - 01/2021
2	TESIBA 09/2022 - 07/2013
2	Transaminases (Aminotransferases)IBA 12/2020 - 01/2019
2	duvelisibIBA 01/2020 - 12/2018
2	Biomarkers (Surrogate Marker)IBA 05/2019 - 08/2012
2	AntibodiesIBA 03/2016 - 01/2004
2	Lenalidomide (CC 5013)FDA Link 01/2016 - 03/2012
2	pro-brain natriuretic peptide (1-76)IBA 08/2012 - 05/2010
2	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2012 - 05/2010
2	Warfarin (Coumadin)FDA LinkGeneric 06/2011 - 11/2003
2	Alkylating AgentsIBA 09/2007 - 05/2002
2	purineIBA 01/2004 - 08/2003
1	InterferonsIBA 06/2023
1	Indicators and Reagents (Reagents)IBA 11/2021
1	Peptides (Polypeptides)IBA 01/2021
1	ravulizumabIBA 01/2021
1	deoxyguanosine triphosphate (dGTP)IBA 12/2020
1	forodesineIBA 12/2020

Therapy/Procedure

51	Therapeutics 05/2024 - 03/2002
8	Drug Therapy (Chemotherapy) 11/2019 - 03/2002
4	Aftercare (After-Treatment) 12/2023 - 05/2002
2	Immunotherapy 12/2022 - 04/2010
2	Blood Transfusion (Blood Transfusions) 12/2013 - 01/2009
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2024